Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ThermoGenesis Holdings, Inc. (THMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
At close: 04:00PM EST
0.9700 -0.03 (-3.00%)
After hours: 06:56PM EST
Advertisement
Sign in to post a message.
  • b
    bryan
    I still believe.
  • b
    bryan
    I belive
  • b
    bryan
    over 1.20 at close
  • b
    bryan
    that will work out fine just keep adding
  • z
    zig
    Be careful... NO CASH. Might do an offering.. A year ago i think was the last time they offer.
  • b
    bryan
    this should be nice
  • b
    bryan
    That tomorrow's Tuesday report, yes
  • b
    bryan
    Tuesday's report should be nice.
  • a
    ahmed
    Uts now or never
  • T
    Tom
    see you at 5$
    Bullish
  • b
    bryan
    tomarrow
  • b
    bryan
    In the money.
  • D
    Darkesmoke
    Fleas.
  • D
    DaveMc
    OK, so it's very much a spec but it is a decent position to be in. If they can reduce the cost of CAR-T therapy (a hugely growing industry) then they are in a good position. Corning's involvement and 98% q/Q growth seems like a decent validation (previous covid slowdowns and small numbers do contribute, but still a good result). I'm not buying more just yet, but I see some blue sky on the horizon.
  • T
    Tomkila
    First price target $2,5, 4, 5,10!!
    Bullish
  • u
    uihyun
    cell and gene theraphy
  • b
    bob
    Interesting we are at 6.40. I am from Sacramento and I can tell you there has been no mention about serology testing kits outside of this company on local fox and local CBS. A lot of university institutions in Northern California have developed their own in house tests like Stanford’s. However the local university UC Davis has been somewhat quiet, and I think if we want to pursue an expedited FDA EUA like Chembio we should affiliate ourselves with UC Davis. Dr. Xu, our CEO, has a lot of big Chinese backers given that he serves as president at BoyAlife, to which they list our company has a subsidiary of theirs. I imagine they will pump this full of capital given they have at least 30 subsidiaries. I like how Renaissance Technologies, one of the most successful hedge funds if not the most, has a 130k shares as of March 31.

    With evaluation of testing within this population, we can corner the 2 mil. population+ in Sacramento and work our way north and south, since Abbott will be stretched thin throughout the country (Abbott has a longstanding contract with the VA here but I can tell you that it’s been slow to start up here)

    I think what makes our unique is the fact we can also start our convalescing plasma trials Simultaneously while starting to gather local data with the antibody testing.

    Bottom line:
    Significantly undervalued
    Bullish
  • j
    jung
    let's do some valuation comparison. CODX $300 mil, AYTU $115 mil, THMO $30 mil. And CODX and AYTU is valued for that just for test kits alone. But THMO also has possible cure, 'convalescent plasma therapy' in its sleeve which is not well known just yet.
    Even just to catch up with AYTU valuation alone THMO should be $24. However, once convalescent plasma therapy gains some traction and being used more prominently...it'll be huge.
    use any weakness to load up.
  • M
    Mark
    should be a good week
  • H
    Hold my Bag plz
    is this will continue down trend or what , seriously there is no clue about this ..any advice...
Advertisement
Advertisement